<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37168753</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2691-171X</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>JPGN reports</Title><ISOAbbreviation>JPGN Rep</ISOAbbreviation></Journal><ArticleTitle>Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection.</ArticleTitle><Pagination><StartPage>e152</StartPage><MedlinePgn>e152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PG9.0000000000000152</ELocationID><Abstract><AbstractText>In addition to the severe impact of acute respiratory disease during the SARS-CoV-2 pandemic, the issue of "Long COVID" illness has impacted large numbers of patients following the initial infection. Wide ranges of Long Covid incidence have been reported, ranging from 30 to 87%. Long COVID has a variety of clinical manifestations, including gastrointestinal symptoms. Here, we report a case of persistent abdominal pain, 3 months following a SARS-CoV-2 diagnosis, associated with chronic colonic inflammation and the presence of mucosal SARS-CoV-2 virions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Wolters Kluwer on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arostegui</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Kenny</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarz</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaidy</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabinowitz</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallach</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JPGN Rep</MedlineTA><NlmUniqueID>101773885</NlmUniqueID><ISSNLinking>2691-171X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37168753</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="doi">10.1097/PG9.0000000000000152</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003;81:197&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572419</ArticleId><ArticleId IdType="pubmed">12764516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Rong L, Nian W, et al. . Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51:843&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161803</ArticleId><ArticleId IdType="pubmed">32222988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, et al. . Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting the challenge of long COVID. Nature Medicine. 2020;26:1803&#x2013;1803.</Citation><ArticleIdList><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury-Hanold W, Yordy B, Kong P, et al. . Viral spread to enteric neurons links genital HSV-1 infection to toxic megacolon and lethality. Cell Host Microbe. 2016;19:788&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4902295</ArticleId><ArticleId IdType="pubmed">27281569</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nature Medicine. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JJL. Persistent SARS-2 infections contribute to long COVID-19. Med Hypotheses. 2021;149:110538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkeri R, Goebel S, Sharma GD. SARS-CoV-2 shedding from asymptomatic patients: Contribution of potential extrapulmonary tissue reservoirs. Am J Trop Med Hyg. 2020;103:18&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7356473</ArticleId><ArticleId IdType="pubmed">32406369</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitan D, London V, McLaren RA, et al. . Histologic and immunohistochemical evaluation of 65 placentas from women with polymerase chain reaction-proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Arch Pathol Lab Med. 2021;145:648&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">33596304</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Fan Y, Lai Y, et al. . Coronavirus infections and immune responses. J Med Virol. 2020;92:424&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166547</ArticleId><ArticleId IdType="pubmed">31981224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, et al. . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158:1518&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130192</ArticleId><ArticleId IdType="pubmed">32142785</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, et al. . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181:281&#x2013;292. e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G, Lenti MV, Cremon C, et al. . Implications of SARS-CoV-2 infection for neurogastroenterology. Neurogastroenterol Motil. 2021;33:e14104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7995160</ArticleId><ArticleId IdType="pubmed">33591607</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xe4;ndriks L. The angiotensin II type 2 receptor and the gastrointestinal tract. J Renin Angiotensin Aldosterone Syst. 2010;11:43&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19861352</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xe4;ndriks L. The renin-angiotensin system and the gastrointestinal mucosa. Acta Physiol (Oxf). 2011;201:157&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">20626369</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Angus PW, Burrell LM, et al. . Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther. 2012;35:414&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159631</ArticleId><ArticleId IdType="pubmed">22221317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yoon GY, Myoung J, et al. . Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Emerg Microbes Infect. 2020;9:2169&#x2013;2179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7580600</ArticleId><ArticleId IdType="pubmed">32969768</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zald&#xed;var EE, Hern&#xe1;ndez-Sapi&#xe9;ns MA, Minjarez B, et al. . Infection mechanism of SARS-COV-2 and its implication on the nervous system. Frontiers in Immunology. 2021;11:621735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7878381</ArticleId><ArticleId IdType="pubmed">33584720</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito G, Pesce M, Seguella L, et al. . Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? Brain Behav Immun. 2020;87:93&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179488</ArticleId><ArticleId IdType="pubmed">32335192</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiho H, Ihara E, Motomura Y, et al. . Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol. 2011;2:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196622</ArticleId><ArticleId IdType="pubmed">22013552</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun P, Qesari M, Marconi PC, et al. . Herpes simplex virus Type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment. Frontiers in Cellular and Infection Microbiology. 2018;8:74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5862801</ArticleId><ArticleId IdType="pubmed">29600197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon M, Gershon A. Varicella-zoster virus and the enteric nervous system. The Journal of Infectious Diseases. 2018;218:S113&#x2013;S119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6151087</ArticleId><ArticleId IdType="pubmed">30247599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellono NW, Bayrer JR, Leitch DB, et al. . Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell. 2017;170:185&#x2013;198. e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5839326</ArticleId><ArticleId IdType="pubmed">28648659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tande AJ, Pollock BD, Shah ND, et al. . Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening [published online ahead of print March 10, 2021]. Clin Infect Dis. doi: 10.1093/cid/ciab229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989519</ArticleId><ArticleId IdType="pubmed">33704435</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleem A, Slenker AK. Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright &#xa9; 2021, StatPearls Publishing LLC., 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033365</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb P, Molla MMA, Saif-Ur-Rahman KM. An update to monoclonal antibody as therapeutic option against COVID-19. Biosaf Health. 2021;3:87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872849</ArticleId><ArticleId IdType="pubmed">33585808</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et al. . Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>